|
Compound class:
Synthetic organic
Comment: GS-1069518 is the active metabolite of the orally bioavailable prodrug emvistegrast (GS-1427) [1]. It is a potent and selective inhibitor of the α4β7 integrin.
|
|
|||||||||||||||||||||||||||||||||||
| No information available. |
Pharmacokinetics ![]() |
| Biotransformation/Metabolism |
| GS-1069518 is metabolized by CYP3A and UGT1A3, and is a substrate of MRP2, P-gp, BCRP, and OATPs [1]. |